Skip links

DAWNZERA™ (donidalorsen)

Full Name DAWNZERA™ (donidalorsen)
Drug donidalorsen
Manufacturer Ionis Pharmaceuticals
Route of Administration Subcutaneous
Site of Care Home
Approved Indication Prophylaxis to prevent attacks of hereditary angioedema (HAE) in adult and pediatric patients 12 years of age and older.
Disease Hereditary Angioedema (HAE)
Therapeutic Area Allergy & Immunology
Enrollment Form Link Enrollment Form
Phone Number 844-444-4305
Fax Number 877-558-0007
Product Website dawnzera.com
Patient Resources HAEA